Cite

    Velcheti, V. et al. (2015). Novel pharmacologic approach to enhance the epigenetic and immune priming effect of decitabine in patients with advanced non-small cell lung cancer. Journal for immunotherapy of cancer. 3 (2), pp. 1-2. [Online].